To resolve a spate of whistleblower lawsuits, drug manufacturer Cephalon Inc. of Frazer, Pa., has agreed to pay $431 million in civil and criminal fines for illegally promoting "off-label" uses for three of its drugs, federal prosecutors said.
Cephalon also announced that it has agreed to pay $6.15 million to Connecticut and $700,000 to Massachusetts to settle related investigations by the attorneys general of those states.
As part of the Justice Department settlement, Cephalon agreed to enter into a five-year "corporate integrity agreement" that requires the company to send doctors a letter about the settlement and give them a means to report questionable conduct of sales representatives.
Learn More Here.
